Notizia - Recent Pharma, Healthcare and Biotech Happenings

AlivaMab Discovery Services (ADS) has announced an antibody discovery agreement against multiple targets with Janssen Research & Developments. AlivaMab, a pharmaceutical providing fully human therapeutic antibody discovery services, will render its therapeutic antibody candidates, its clinical expertise and R&D capabilities to Janssen. ADS will use its Mouse platform which is already widely used by its own Research team to produce antibodies against multiple targets for Janssen to evaluate. The AlivaMab Mouse has been licensed to eight of the top 15 pharmaceutical companies, along with the several other public and private companies. The financial t...